NC-LENOVO
28.5.2024 20:33:33 CEST | Business Wire | Press release
Lenovo has once again been ranked in the Gartner Supply Chain Top 25 for 2024, ranking tenth in this list of global companies with exceptional supply chains. The Gartner Supply Chain Top 25 is a renowned annual ranking of the world’s superior supply chains. From financial and corporate social responsibility data and community opinion, the Gartner Supply Chain Top 25 for 2024 report, celebrates and profiles companies demonstrating excellence in supply chain management.
Over the last 12 months, Lenovo has intensified its focus on key areas in its supply chain, including security, digital transformation, and environmental sustainability, alongside the company’s global/local approach to drive greater efficiencies and improved customer outcomes.
Today, Lenovo’s global hybrid manufacturing network includes 30+ manufacturing sites spanning 10 markets in the 180 markets Lenovo does business in, including Argentina, Brazil, China, Germany, Hungary, India, Japan, Mexico, and the US. This ensures the supply chain remains resilient and can adapt to any disruption.
Lenovo’s supply chain is one of the clearest examples of its global/local strategy and delivers not only operational efficiencies for the business but a definitive advantage to customers through a focus on manufacturing in Europe for Europe, the Americas for the Americas, and Asia for Asia. Bringing manufacturing closer to customers shortens the local supply chain, utilizes the local skilled labor force, and supports Lenovo's sustainability goals through more sustainable manufacturing methods. Building devices close to customers dramatically reduce the freight miles these products incur, providing more efficient and sustainable transportation options. As an example, since becoming operational in 2022, Lenovo’s European manufacturing facility in Hungary has shipped over 1.5 million workstations and servers to over 2,500 customers in 70 markets across EMEA.
Che Min (Jammi) Tu, Senior Vice President and Group Operations Officer, Lenovo, said, “Our supply chain has always been a towering strength for Lenovo and remains fundamental to our future success. Over the past few years, we’ve seen the topic of supply chains make headlines around the world when the flow of goods is impacted and the knock-on effect this has on a business and its reputation. What’s clearer than ever today is that a company’s supply chain is a competitive advantage and can no longer be considered a cost center. In fact, at Lenovo, we’ve successfully transitioned our global supply chain into a commercial center and profit pool. We are also pioneering Manufacturing as a Service, as well as developing and incubating new technologies and solutions within our manufacturing facilities and logistics services that we can offer our customers. For us, we’re incredibly proud that we continue to be recognized as having one of the most exceptional supply chains in the world across all industries.”
Lenovo's commitment to delivering innovation, efficiency, and resilience to customers worldwide is underpinned by its resilient supply chain, ensuring cutting-edge products reach customers securely.
Lenovo's supply chain security approach is built on a foundation of prevention. Suppliers and components are vigorously vetted, with the company’s security-by-design approach embedded into the product lifecycle. By taking a proactive stance against backdoors, tainted products, counterfeits, and hardware/software vulnerabilities, Lenovo safeguards its products and sets a high industry standard for supply chain security.
Doug Fisher, SVP and Chief Security Officer, Lenovo, said, “Lenovo is dedicated to driving supply chain security through leadership, so we remain in front of the supply chain evolution. Our goal is to ensure our products are safe, highly resilient, and trustworthy before entering our customers’ environment. We attest to the integrity of each device right down to the lowest levels in the system.”
Lenovo also remains committed to ESG. It was in the first group of companies and the first PC and smartphone maker to have targets validated in alignment to Science Based Targets initiative’s Net-Zero Standard. It continues to focus on future-proofing its operations by making the supply chain more robust, adaptable, and profitable and recently released Lenovo ESG Navigator, a digital solution for collecting and measuring ESG data points – like energy use - from factory sites in real time.
With the development of an AI-powered ESG assessment system such as Lenovo’s Intelligence Sustainability Solutions Advisor (LISSA), Lenovo is empowering customers with actionable sustainability insights from across the global supply chain to understand the estimated emissions impact across their IT lifecycle and make critical decisions to decrease emissions. Initially developed to support supply chain decision-making, LISSA has now been commercially deployed to support customers’ IT sustainability goals.
As part of Lenovo’s drive towards the circular economy, utilizing the supply chain for customers’ after-sales support, where possible, returned components are repaired by engineers, quality-tested, and reused. To date, 4m+ components, including motherboards, processors, drives, memory, and more, have been diverted from landfills for reuse within the product lifecycle.
About the Gartner Supply Chain Top 25 ranking and methodology
The Supply Chain Top 25 ranking comprises two main components: business performance and opinion. Business performance in the form of public financial and ESG (environmental, social, governance) data provides a view into how companies have performed in the past three years, while the opinion component offers an eye to future potential and reflects leadership in the supply chain community. These two components are combined into a total composite score.
Gartner derives a list of companies from a combination of the Fortune Global 500 and the Forbes Global 2000. In an effort to maintain the list of companies evaluated at a manageable level, a general annual revenue threshold of $15 billion has been applied and companies without physical supply chains are excluded.
Read the full Gartner Supply Chain Top 25 for 2024 Report here.
Gartner Press Release: Gartner Announces 20th Annual Rankings of the Global Supply Chain Top 25, May 22, 2024.
Gartner Insights, The Gartner Supply Chain Top 25 for 2024, https://www.gartner.com/en/supply-chain/research/supply-chain-top-25.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240528610799/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
